Dr. Eric Klein on genomic testing for genitourinary cancers

“It’s really fascinating how the field is expanding,” Klein says.

“[Genomic testing is] going to be a routine part of prostate cancer care and urologic cancer care going forward,” Eric A. Klein, MD, says in this video. Klein is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic.

Related Content:

UTvProstate Cancer
Dr. Zillioux discusses same-day discharge for FPMRS procedures
What music do urologists listen to in the OR?
Obesity Paradox in prostate cancer: potential explanations and next research steps